Cue Biopharma (CUE) EPS (Basic) Growth (3y) (2020 - 2025)
Cue Biopharma (CUE) EPS (Basic) Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -38.31% |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - | -16.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.01% |
| Sep 30, 2025 | 36.40% |
| Jun 30, 2025 | 25.97% |
| Mar 31, 2025 | 20.79% |
| Dec 31, 2024 | 13.54% |
| Sep 30, 2024 | 25.45% |
| Jun 30, 2024 | 1.81% |
| Mar 31, 2024 | 14.97% |
| Dec 31, 2023 | 8.84% |
| Sep 30, 2023 | 8.21% |
| Jun 30, 2023 | 7.70% |
| Mar 31, 2023 | 16.81% |
| Dec 31, 2022 | -1.50% |
| Sep 30, 2022 | -0.42% |
| Jun 30, 2022 | 6.31% |
| Mar 31, 2022 | 10.89% |
| Dec 31, 2021 | 22.22% |
| Sep 30, 2021 | 10.06% |
| Jun 30, 2021 | 3.11% |
| Mar 31, 2021 | -0.63% |